Corient Capital Partners, LLC Catabasis Pharmaceuticals, Inc. Transaction History

Corient Capital Partners, LLC

  • $1.34 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
N/A
-55,334 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
N/A
-48,189 Reduced 46.55%
55,334 $117,000
Q1 2021

May 17, 2021
BUY
N/A
103,523 New
103,523 $299,000

About Catabasis Pharmaceuticals, Inc.

CATB Quotes by TradingView
  • Ticker CATB
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,948,800
  • Market Cap $657M
More about CATB
Track This Portfolio

Track Corient Capital Partners, LLC Portfolio

Follow Corient Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email